Prestige Consumer Healthcare (PBH) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Prestige Consumer Healthcare Revenue Highlights

Latest Revenue (Y)

$1.13B

Latest Revenue (Q)

$283.55M

Main Segment (Y)

Women's Health

Main Geography (Y)

North American OTC Healthcare

Prestige Consumer Healthcare Revenue by Period

Prestige Consumer Healthcare Revenue by Year

Date	Revenue	Change
2024-03-31	$1.13B	-0.21%
2023-03-31	$1.13B	3.76%
2022-03-31	$1.09B	15.21%
2021-03-31	$943.37M	-2.04%
2020-03-31	$963.01M	-1.31%
2019-03-31	$975.78M	-6.28%
2018-03-31	$1.04B	18.04%
2017-03-31	$882.06M	9.40%
2016-03-31	$806.25M	12.82%
2015-03-31	$714.62M	18.73%
2014-03-31	$601.88M	-3.48%
2013-03-31	$623.60M	41.38%
2012-03-31	$441.08M	31.08%
2011-03-31	$336.51M	11.42%
2010-03-31	$302.02M	-3.42%
2009-03-31	$312.71M	-4.25%
2008-03-31	$326.60M	2.50%
2007-03-31	$318.63M	7.40%
2006-03-31	$296.67M	-2.19%
2005-03-31	$303.32M	244.99%
2004-03-31	$87.92M	22.56%
2003-03-31	$71.73M	55.09%
2002-03-31	$46.25M	434.41%
2001-03-31	$8.65M	-

Prestige Consumer Healthcare generated $1.13B in revenue during NA 2024, up -0.21% compared to the previous quarter, and up 115.33% compared to the same period a year ago.

Prestige Consumer Healthcare Revenue by Quarter

Date	Revenue	Change
2024-09-30	$283.55M	6.14%
2024-06-30	$267.14M	-3.56%
2024-03-31	$276.99M	-2.03%
2023-12-31	$282.74M	-1.25%
2023-09-30	$286.32M	2.51%
2023-06-30	$279.31M	-2.29%
2023-03-31	$285.87M	3.75%
2022-12-31	$275.52M	-4.75%
2022-09-30	$289.27M	4.41%
2022-06-30	$277.06M	3.79%
2022-03-31	$266.94M	-2.74%
2021-12-31	$274.47M	-0.64%
2021-09-30	$276.23M	2.62%
2021-06-30	$269.18M	13.21%
2021-03-31	$237.76M	-0.43%
2020-12-31	$238.79M	0.58%
2020-09-30	$237.42M	3.50%
2020-06-30	$229.39M	-8.69%
2020-03-31	$251.24M	4.01%
2019-12-31	$241.55M	1.46%
2019-09-30	$238.07M	2.55%
2019-06-30	$232.15M	-3.68%
2019-03-31	$241.03M	-0.16%
2018-12-31	$241.41M	0.86%
2018-09-30	$239.36M	-5.76%
2018-06-30	$253.98M	-0.78%
2018-03-31	$255.97M	-5.41%
2017-12-31	$270.62M	4.88%
2017-09-30	$258.03M	0.57%
2017-06-30	$256.57M	6.61%
2017-03-31	$240.67M	11.03%
2016-12-31	$216.76M	0.80%
2016-09-30	$215.05M	2.61%
2016-06-30	$209.57M	0.83%
2016-03-31	$207.85M	3.83%
2015-12-31	$200.19M	-2.85%
2015-09-30	$206.06M	7.25%
2015-06-30	$192.13M	1.10%
2015-03-31	$190.05M	-3.83%
2014-12-31	$197.61M	9.01%
2014-09-30	$181.27M	24.41%
2014-06-30	$145.70M	1.00%
2014-03-31	$144.26M	-1.34%
2013-12-31	$146.21M	-13.20%
2013-09-30	$168.44M	17.82%
2013-06-30	$142.97M	-7.47%
2013-03-31	$154.51M	-3.57%
2012-12-31	$160.23M	-1.00%
2012-09-30	$161.85M	10.11%
2012-06-30	$147.00M	9.70%
2012-03-31	$134.00M	26.11%
2011-12-31	$106.25M	0.67%
2011-09-30	$105.54M	10.76%
2011-06-30	$95.30M	-1.11%
2011-03-31	$96.36M	6.35%
2010-12-31	$90.61M	15.71%
2010-09-30	$78.30M	6.64%
2010-06-30	$73.42M	2.86%
2010-03-31	$71.38M	-5.39%
2009-12-31	$75.45M	-10.37%
2009-09-30	$84.18M	14.96%
2009-06-30	$73.22M	3.35%
2009-03-31	$70.85M	-11.74%
2008-12-31	$80.28M	-8.83%
2008-09-30	$88.05M	19.74%
2008-06-30	$73.53M	-8.58%
2008-03-31	$80.43M	-

Prestige Consumer Healthcare generated $283.55M in revenue during Q2 2025, up 6.14% compared to the previous quarter, and up 101.52% compared to the same period a year ago.

Prestige Consumer Healthcare Revenue Breakdown

Prestige Consumer Healthcare Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Analgesics	$117.45M	-	-	-	-
Cough and Cold	$119.02M	-	-	-	-
Dermatologicals	$129.10M	-	-	-	-
Eye and Ear Care	$179.42M	-	-	-	-
Gastrointestinal	$231.61M	-	-	-	-
Oral Care	$96.31M	-	-	-	-
Other OTC	$12.03M	-	-	-	-
Women's Health	$240.42M	-	-	-	-
Product and Service, Other	-	$107.00K	$42.00K	$41.00K	$74.00K
Product	-	$1.13B	$1.09B	$943.32M	$962.94M

Prestige Consumer Healthcare's latest annual revenue breakdown by segment (product or service), as of Mar 24: Women's Health (21.36%), Gastrointestinal (20.58%), Eye and Ear Care (15.94%), Dermatologicals (11.47%), Cough and Cold (10.58%), Analgesics (10.44%), Oral Care (8.56%), and Other OTC (1.07%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Analgesics	$28.22M	$55.82M	$30.27M	$31.36M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Women's Health	$60.35M	$120.08M	$58.27M	$62.07M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other OTC	$3.16M	$6.17M	$3.11M	$2.75M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Oral Care	$24.08M	$50.06M	$23.46M	$22.78M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gastrointestinal	$60.06M	$117.22M	$61.63M	$52.76M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Eye and Ear Care	$42.79M	$87.48M	$45.07M	$46.87M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dermatologicals	$35.85M	$66.85M	$27.77M	$34.49M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cough and Cold	$29.27M	$52.61M	$33.17M	$33.23M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	$279.30M	$285.83M	$275.50M	$289.26M	$277.02M	$266.93M	$274.45M	$276.22M	$269.17M	$237.75M	$238.78M	$237.41M	$229.38M	$251.21M	$241.54M	$238.05M
Product and Service, Other	-	-	-	-	$10.00K	$34.00K	$29.00K	$9.00K	$35.00K	$9.00K	$16.00K	$8.00K	$9.00K	$9.00K	$9.00K	$13.00K	$10.00K	$28.00K	$7.00K	$18.00K

Prestige Consumer Healthcare's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Women's Health (21.27%), Gastrointestinal (21.16%), Eye and Ear Care (15.08%), Dermatologicals (12.63%), Cough and Cold (10.32%), Analgesics (9.94%), Oral Care (8.49%), and Other OTC (1.11%).

Prestige Consumer Healthcare Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
North American OTC Healthcare	$958.26M	-	-	-	-
Non-US	-	$174.50M	$176.71M	$144.33M	$150.36M
UNITED STATES	-	$953.22M	$910.11M	$799.04M	$812.65M

Prestige Consumer Healthcare's latest annual revenue breakdown by geography, as of Mar 24: North American OTC Healthcare (100.00%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
North American OTC Healthcare	$239.81M	$422.32M	$236.56M	$244.42M	$54.95M	$242.32M	$53.92M	$59.38M	$61.18M	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	-	-	-	$47.36M	$46.76M	$40.07M	$42.51M	$38.65M	$41.49M	$34.13M	$30.05M	$42.84M	$37.63M	$38.35M
UNITED STATES	-	-	-	-	-	-	-	-	-	$219.57M	$227.72M	$236.15M	$226.67M	$199.11M	$197.30M	$203.29M	$199.35M	$208.39M	$203.92M	$199.71M

Prestige Consumer Healthcare's latest quarterly revenue breakdown by geography, as of Sep 24: North American OTC Healthcare (100.00%).

Prestige Consumer Healthcare Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PBH	Prestige Consumer Healthcare	$1.13B	$283.55M
PAHC	Phibro Animal Health	$977.89M	$273.16M
EVO	Evotec SE	$781.43M	$208.73M
PCRX	Pacira BioSciences	$674.98M	$168.57M
SUPN	Supernus Pharmaceuticals	$607.52M	$175.69M
AMPH	Amphastar Pharmaceuticals	$593.24M	$188.82M
COLL	Collegium Pharmaceutical	$566.77M	$159.30M
ANIP	ANI Pharmaceuticals	$486.82M	$148.33M
RGC	Regencell Bioscience	-	-

PBH Revenue FAQ

What is Prestige Consumer Healthcare’s yearly revenue?

Prestige Consumer Healthcare's yearly revenue for 2024 was $1.13B, representing a decrease of -0.21% compared to 2023. The company's yearly revenue for 2023 was $1.13B, representing an increase of 3.76% compared to 2022. PBH's yearly revenue for 2022 was $1.09B, representing an increase of 15.21% compared to 2021.

What is Prestige Consumer Healthcare’s quarterly revenue?

Prestige Consumer Healthcare's quarterly revenue for Q2 2025 was $283.55M, a 6.14% increase from the previous quarter (Q1 2025), and a -0.97% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $267.14M, a -3.56% decrease from the previous quarter (Q4 2024), and a -4.36% decrease year-over-year (Q1 2024). PBH's quarterly revenue for Q4 2024 was $276.99M, a -2.03% decrease from the previous quarter (Q3 2024), and a -3.11% decrease year-over-year (Q4 2023).

What is Prestige Consumer Healthcare’s revenue growth rate?

Prestige Consumer Healthcare's revenue growth rate for the last 3 years (2022-2024) was 3.55%, and for the last 5 years (2020-2024) was 16.86%.

What are Prestige Consumer Healthcare’s revenue streams?

Prestige Consumer Healthcare's revenue streams in r 24 are Analgesics, Cough and Cold, Dermatologicals, Eye and Ear Care, Gastrointestinal, Oral Care, Other OTC, and Women's Health. Analgesics generated $117.45M in revenue, accounting 10.44% of the company's total revenue Cough and Cold generated $119.02M in revenue, accounting 10.58% of the company's total revenue Dermatologicals generated $129.1M in revenue, accounting 11.47% of the company's total revenue Eye and Ear Care generated $179.42M in revenue, accounting 15.94% of the company's total revenue Gastrointestinal generated $231.61M in revenue, accounting 20.58% of the company's total revenue Oral Care generated $96.3M in revenue, accounting 8.56% of the company's total revenue Other OTC generated $12.02M in revenue, accounting 1.07% of the company's total revenue Women's Health generated $240.42M in revenue, accounting 21.36% of the company's total revenue

What is Prestige Consumer Healthcare’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Prestige Consumer Healthcare was Women's Health. This segment made a revenue of $240.42M, representing 21.36% of the company's total revenue.